Back to search

Article

Efficacy and safety of a triple combination of glucocorticoids, tofacitinib and calcineurin inhibitors in anti-MDA5 positive dermatomyositis

2022-09-02

Abstract excerpt

<h4>Objectives: </h4> To explore the risk factors of early death in dermatomyositis patients positive with anti-melanoma differentiation-related gene 5 (anti-MDA5) antibody (anti-MDA5-DM). To determine the optimal initial treatment regimen for patients with anti-MDA5-DM. <h4>Methods: </h4> . Patients with newly onset anti-MDA5-DM from June 2018 to October 2021 in our center were retrospectively reviewed for 6 mont...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2a0fed76-5f0e-5e32-95a9-2bd9175ded5d
DOI
10.21203/rs.3.rs-2015911/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy and safety of a triple combination of glucocorticoids, tofacitinib and calcineurin inhibitors in anti-MDA5 positive dermatomyositisDOI 10.21203/rs.3.rs-2015911/v1
A retrospective study for clinical characteristics of 293 patients with dermatomyositis.Semantic proximity
Compounded sulfamethoxazole improved the prognosis of dermatomyositis patients positive with anti-melanoma differentiation-associated gene 5Semantic proximity
Clinical Features and a Nomogram for Predicting Infection in Anti-MDA5 Antibody-Positive Dermatomyositis: A Single-Center Retrospective StudySemantic proximity
Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses.Semantic proximity
Anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody dermatomyositis: Clinical features and outcomes in a racially diverse patient cohortSemantic proximity
Clinical phenotype and prognostic determinants of spontaneous pneumomediastinum in anti-MDA5 antibody-positive dermatomyositis.Semantic proximity
Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicrySemantic proximity
Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon SystemSemantic proximity
Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.Semantic proximity
Transcriptomic profiling and longitudinal study reveal the relationship of anti-MDA5 titer and type I IFN signature in MDA5+ dermatomyositisSemantic proximity
Identification of Three Different Phenotypes in Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease.Semantic proximity
Profile of patients with Juvenile Dermatomyositis and Anti-MDA5 autoantibodiesSemantic proximity
Select a neighboring publication to make it the new centre.